COMMUNIQUÉS West-GlobeNewswire

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
12/02/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions [...]
CartoChrome Aids Home Buyers with Health Score, Addressing a $150 Billion Healthcare Accessibility Issue
12/02/2024
LOS ANGELES, Feb. 12, 2024 (GLOBE NEWSWIRE) -- In an ambitious effort to address a $150 billion problem in healthcare accessibility, CartoChrome has launched a solution that expertly integrates healthcare data into the [...]
Assure Holdings Corp. Announces Business Combination with Danam Health, Inc.
12/02/2024
Danam Health, Inc., a private pharmaceutical and healthcare services company, to merge with Assure Holdings Corp. in an all-stock transaction DENVER, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure”) ( [...]
Solera Chief Medical Officer Dr. Byron Crowe Recognized as One of Modern Healthcare’s 40 Under 40
12/02/2024
CHICAGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Solera Health , the premier technology platform for connecting people seamlessly and easily to health solutions that work, today announced that Dr. Byron Crowe , the company’s [...]
HeartSciences Expands its Scientific Advisory Board
12/02/2024
Southlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology [...]
INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
12/02/2024
Boca Raton, Florida, Feb. 12, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s [...]
T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
12/02/2024
Increases number of bacteria species detected with addition of Acinetobacter baumannii LEXINGTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis- [...]
BlueSprig Pediatrics Sponsors Armani Williams Ahead of the Daytona ARCA 200
12/02/2024
The partnership with Williams, who has autism, will bring BlueSprig’s work with children with autism to the spotlight DAYTONA BEACH, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Blue Sprig Pediatrics, Inc. (BlueSprig) , a [...]
Signati™ Medical, Inc. Announces Board Member Dr. Jones Joins Urology Austin
12/02/2024
Providence, RI, Feb. 12, 2024 (GLOBE NEWSWIRE) -- LeRoy Jones, MD, Board-Certified Urologist and Signati™ Medical, Inc. Board Member, starts a new chapter in his career at Urology Austin. Dr. Jones has been on the [...]
Jaya Biosciences Presents Promising Preclinical Data in Alzheimer’s Disease at the 20th Annual WORLDSymposium™ 2024
12/02/2024
- Study results highlight potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s - SOUTH SAN FRANCISCO, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Jaya Biosciences, Inc [...]
Accelus Strengthens Leadership with New Board Appointments
12/02/2024
Accelus CEO & Industry Veteran Kevin McGann and High-Performance Management Expert Bernie Haffey to Join as New Directors PALM BEACH GARDENS, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Accelus , a privately held [...]
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
12/02/2024
Advancements provide workflow efficiencies for NeuroStar® TMS providers MALVERN, Pa., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, [...]
Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer
12/02/2024
SAN CLEMENTE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today [...]
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases
12/02/2024
Poster presentation unveils Corvus’ next-generation ITK inhibitor candidates designed to deliver precise T cell modulation for immunology indications BURLINGAME, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Corvus [...]
Ruxoprubart (NM8074) Scores FDA Orphan Drug Designation for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment
12/02/2024
FDA grants orphan drug designation to Ruxoprubart (NM8074) for the treatment of PNH. Ruxoprubart is an Anti-Bb antibody that selectively blocks the alternative pathway while maintaining the intactness of the classical [...]
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
12/02/2024
FREMONT, CA , Feb. 12, 2024 (GLOBE NEWSWIRE) -- The Company holds a U.S. patent for the same treatment via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company [...]
Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions
12/02/2024
Oak Ridge, TN, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today announces two significant new customer transactions with Daxor’s BVA-100 [...]
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
12/02/2024
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, provides an update of its Priority Original Abbreviated [...]
MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28
12/02/2024
MARIETTA, Ga., Feb. 12, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year [...]

Pages